NeuroSports
Volume 2

Issue 1

Article 2

October 2022

Three-month recovery from common negative physical, functional, and
psychosocial effects among individuals infected with COVID-19: a single
observational group repeated measure study
Hussain I. Aslan
University of Saskatchewan, hussain.aslan@usask.ca
Scotty J. Butcher PhD
University of Saskatchewan, scotty.butcher@usask.ca
Darcy D. Marciniuk MD
University of Saskatchewan, darcy.marciniuk@usask.ca
Corey R. Tomczak PhD
University of Saskatchewan, corey.tomczak@usask.ca

Follow this and additional works at: https://nsuworks.nova.edu/neurosports
Part of the Exercise Science Commons, Neuroscience and Neurobiology Commons, and the Sports
Sciences Commons

Recommended Citation
Aslan, Hussain I.; Butcher, Scotty J. PhD; Marciniuk, Darcy D. MD; and Tomczak, Corey R. PhD (2022)
"Three-month recovery from common negative physical, functional, and psychosocial effects among
individuals infected with COVID-19: a single observational group repeated measure study," NeuroSports:
Vol. 2: Iss. 1, Article 2.
Available at: https://nsuworks.nova.edu/neurosports/vol2/iss1/2
This Article is brought to you for free and open access by the College of Psychology at NSUWorks. It has been
accepted for inclusion in NeuroSports by an authorized editor of NSUWorks. For more information, please contact
nsuworks@nova.edu.

Three-month recovery from common negative physical, functional, and
psychosocial effects among individuals infected with COVID-19: a single
observational group repeated measure study
Abstract
Purpose: We examined three-month recovery from common negative effects of COVID-19 infection on
select physical, functional, and psychosocial parameters among infected individuals and their
implications for rehabilitation programs. Methods: Twenty-one subjects participated in this study. Four
standardized questionnaires were used to assess dyspnea, physical, and psychosocial variables in this
study. The post-test survey was conducted 90 days following the pre-test survey. Wilcoxon-Signed Rank
test and paired t-test were used to compare the variables data between pre- and post-testing time points.
Results: Dyspnea scores decreased from (pre: 2 vs post:1, Z=-3.276, p=0.001, r=.50). Work performance
scores increased from (pre: 42 ±25 vs post: 57 ±21, t(20) =-2.868, p=0.010, r=.62). Social functioning
increased from (pre: 44 ±27 vs post: 60 ±24, t(20) =-3.525, p=0.002, r=.76) and pain scores from (pre: 42
±30 vs post: 53 ±25, t(20) =-2.134, p=0.045, r=.46) also increased across the 90 days. Conclusions: Longterm symptoms after COVID-19 infection include ongoing physical, functional, and psychosocial deficits.
While dyspnea decreased and work performance and social functioning increased, we observed a
concomitant increase in pain scores over the 90-day measurement period. Long-term multidisciplinary
rehabilitation programs should be designed to address the ongoing deficits among this population.
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Introduction
The lasting negative impacts of COVID-19 infection on all aspects of health
among the survivors of the virus is important to understand for patient care as
many individuals experience persistent symptoms following acute infection.
Indeed, an early pandemic report estimated about half of COVID-19 survivors
may require rehabilitation programming to offset persist symptoms related to
infection.1 During the course of infection, individuals with COVID-19 present
with, but not limited to, chest tightness, dyspnea (most common symptom),
cough, fever, headache, diarrhoea, vomiting, general weakness, sputum
production, and dizziness.2–4 Baratto et al.5 reported that individuals displayed
decreased functional capacity and increased exercise hyperventilation during early
recovery from COVID-19. The reduction in functional capacity may be
subsequent to muscle weakness and fatigue from hospital stay,6,7 with persistent
dyspnea, reduced physical activity (PA) and quality of life occurring during the
post-acute phase of COVID-19 infection.8 Furthermore, fatigue and exertional
dyspnea have also reported as the most common symptoms even after 6 months of
discharge from hospital among the survivors of the virus.9 A study of the
medium-term (≈3 months) effects of COVID-19 on organ health and exercise
capacity also revealed that 64% and 55% of the recovered individuals experienced
dyspnea and fatigue, respectively, following 2-3 months from the infection date.10
Together, these previous reports indicate that a significant number of individuals
who become infected with COVID-19 may likely suffer ongoing symptoms that
adversely affect quality of life.
Investigations probing the lasting negative impacts of COVID-19 in
individuals who are infected with the virus on common quality-of-life parameters,
functional status, and ability of performing different intensities of physical
activities are scarce. This knowledge gap has impeded the development of
evidence-based approaches for rehabilitation. Therefore, we objectively examined
three-month recovery from common negative effects of COVID-19 infection on
select physical, functional, and psychosocial parameters among infected
individuals. We hypothesized that participants infected with COVID-19 will have
persistent deficits in physical ability, functional performance, and some
psychosocial parameters at three months post-testing time point.
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Methods
Study Design and Participants
This was a single observational group repeated measure design that recruited 22
participants (21 completed the pre- and post-tests). Participants were recruited
with diagnosis of COVID-19 infection (Positive PCR results/self-reported)
through social media (i.e., Facebook) due the policies of strict lockdowns that
were in effect at the time of conducting this study. All the participants were
unvaccinated at the time of the participation in this study. Information of the study
with the link of the survey was posted 2-3 times a week for 3 months (OctoberDecember 2020). Thirty-nine participants accessed the survey during the 3-month
period. However, only 22 of the participants fully completed the post-test survey.
Consenting participants completed online (SurveyMonkey Inc., San Mateo,
California, USA) standardized questionnaires (detailed below) as well as
information about their infection date, hospitalization status (i.e., hospitalized,
non-hospitalized) gender, age, weight, country, and recovery periods (i.e., time
between date of infection and pre-testing time point).
The pre-test survey occurred during the months of October and December
2020, while the post-test survey occurred during the months of January and
March 2021. The baseline values represented participants’ answers for the
questionnaires at the time of conducting the pre-test. The baseline values
collection date ranged from 1 to 11 month after the date of the positive test with
COVID-19 (i.e., during the recovery time) among the participants. This study was
approved by the University of Saskatchewan-Research Ethics Board (Bio-REB
ID: 2312).
Inclusion criteria of this study were any COVID-19 infected individual
(of any sex) between the age of 30-70 years. Participants with pre-existing
chronic cardiovascular, pulmonary (other than being infected with COVID-19 and
recovered), or musculoskeletal disorders were excluded from participating in this
study. We excluded the participants with the aforementioned health conditions to
avoid introducing confounding factors that may possibly overshadow the impact
of COVID-19 lasting effects.
Scales and Questionnaires
Modified Medical Research Council Dyspnea Scale (mMRC): Similar to
the original MRCDS scale,11 the modified (i.e., mMRC) scale12 uses the same 0-4
descriptors.13]. The mMRC has been validated to assess dyspneic symptom among
chronic obstructive pulmonary disease (COPD) populations.13 Since Both COPD
and COVID-19 can cause dyspnea among affected individuals,4,14,15 we believed
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of its suitability to evaluate the deleterious impacts of COVID-19 on lung
function among recovered subjects from this disease despite the scale not being
exclusively validated for COVID-19 survivors. Further explanation about the use
and suitability of this scale can be found in our former study.8 For this scale, a
change of 0.5 unit represents a minimally important difference (MID).8
The International Physical Activity Questionnaire (IPAQ): IPAQ16 was
employed because of its widespread use for attaining health-related physical
activity data. The (short version) of the IPAQ is comprised of 7 questions that
cover 3 categories of moderate, high, and vigorous activity levels. For IPAQ
scoring, the total MET-minutes/week was calculated as walk (METs = 3.3 × min
× days) + moderate activity (METs = 4.0 × min × days) + vigorous activity
(METs = 8 × min × days).16 Validity of the moderate and vigorous activity
portions were reported as (r = .430 – .557) and (r = .702) for sedentary behaviors
during the weekdays among older adults.17 No MID values were found for IPAQ.
The Functional Status Questionnaire (FSQ): The FSQ18 is a short
questionnaire widely utilized in primary care settings for functional evaluation
(i.e., initial disability screening, and monitoring meaningful changes clinical
status) of ambulatory individuals with health conditions over time.
Comprehensive information related to the physical function in activities of daily
living, psychological, social and role functions and variety of performance
measures. The six scales have an internal consistency ranging from 0.64 to 0.82.18
No MID values were found for FSQ.
The RAND-36 measure of health-related quality of life questionnaire:
The RAND-3619 is a commonly used generic health related quality of life
(HrQoL) survey instrument. The questionnaire includes 36 items that examines
eight health related concepts: physical functioning, role limitations caused by
physical health problems, wellbeing, role limitations caused by emotional
problems, social functioning, energy/fatigue, pain, emotional and general health
perceptions. Linear transformation method was used to score each item to a 0–100
range (% of total possible score) and then averaged.19 For this scale, a change of
(10, 12.5, 12.5, 10, 10, 8.3, 12.5, and 10 point/100) represents a MID for the
physical functioning, role limitations caused by physical health problems,
energy/fatigue, pain, emotional wellbeing, role limitations caused by emotional
problems, social functioning, and general health perceptions, respectively.20
Statistical Analysis
Statistical analyses were be performed using SPSS version 26 (IBM Corp.,
Armonk, New York, USA). Demographic data and data for variables that met the
normal distribution assumption were analyzed using paired t-test. Data for
variables that did not meet the normal distribution assumption, were analyzed
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using the Wilcoxon-Signed Rank test. Data obtained from the questionnaires, are
reported as means, standard deviations (SD), medians, and ranges. Statistical
significance was determined when p < 0.05.

Results
Twenty-two individuals accessed the survey over the period of 6 months (between
October 2020 and March 2021). After excluding incomplete responses, the final
number of participants was 21 (Table 1). Three participants were male. The dates
of infection of the participants in this observational group occurred between
January 2 and October 25, 2020. Four of these participants were hospitalized
(hospitalization periods ranged from 1-12 days, and no participants were admitted
to ICU) due to being infected with COVID-19.
Table 1. Demographics of the participants (n=21) during pre and post time points
presented as mean and standard deviation (SD). Paired t-test was used to examine
significant differences between the time points. Statistical significance was
determined when p < 0.05.
Demographics
Pre
Post
p-value
Age (years)

49.0 ±6.9

49.3 ±6.7

0.010

Weight (kg)

79 ±15

78 ±18

0.530

BMI (unit)

27 ±4

27 ±4

0.507

Height (cm)

170 ±8

170 ±8

0.329

A paired t-test indicated that there were no significant differences between
the pre and post-test values for weight, height, and BMI. By design, age increased
during the study (Table 1)
mMRC & IPAQ. A Wilcoxon Signed-Ranks Test indicated that post-test
mMRC (Mdn = 1) score was significantly lower than pre-test (Md = 2) score, Z =
-3.276, p = 0.001, r = .50. There were no significant differences for the IPAQ
between the scores of the pre and post-test time points in any of the parameters
withing this questionnaire (Table 2).
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Table 2. The outcome scores of dyspnea scale of the mMRC and IPAQ
parameters of the participants (n=21) during pre and post time points presented as
mean, SD, median and range. Paired t-test and Wilcoxon signed-rank tests were
used to explore significant differences between the two time points. Statistical
significance was determined when p < 0.05. Modified Medical Research Council:
mMRC. IPAQ: International Physical Activity Questionnaire. Vig. PA: vigorous
physical activity, Mod. PA: moderate physical activity, Md: median, Rn: range.
Variables

Value

Pre

Post

p-value

Dyspnea scale (scores,0-4)

Md, Rn

2, 4

1, 3

0.001

IPAQ, Vig PA (MET-min/wk)

Md, Rn

0, 23040

0, 10080

0.283

IPAQ, Mod PA (MET-min/wk)

Md, Rn

0, 2160

240, 3360

0.100

IPAQ, Walking (MET-min/wk)

Md, Rn

396, 2772

495, 6930

0.278

IPAQ, Total PA (MET-min/wk) Md, Rn

577, 23817

1893, 12852

0.086

IPAQ, Sitting (min-day)

480, 900

480, 1200

0.710

Md, Rn

FSQ. There was significant difference between the pre (42 ±25) and posttest (57 ±21) scores, t(20) = -2.868, p = 0.010, r = .62. in work performance
favoring post-test scores. No significant differences were found in other
parameters within this questionnaire (Table 3).
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Table 3. The outcome scores (points/100) of the FSQ parameters of the
participants (n=21) during pre and post time points presented as mean, SD,
median and range. Paired t-test and Wilcoxon signed-rank tests were used to
explore significant differences between the two the time points. Statistical
significance was determined when p < 0.05. FSQ: Functional Status
Questionnaire, Md: median, Rn: range.
Variables

Value

Pre

Post

p-value

Basic ADL

Md, Rn

78, 56

78, 133

0.871

Intermediate ADL

Mean, SD

50 ±24

56 ±25

0.171

Mental health

Mean, SD

56 ±16

59 ±15

0.489

Work performance

Mean, SD

42 ±25

57±21

0.010

Social activities

Md, Rn

0, 133

11, 133

0.844

Quality of interactions

Mean, SD

46 ±11

48 ±10

0.431

The single item questions’ answers for both testing time points of the
FSQ presented as percentages (Table 4).
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Table 4. Single item results of the Functional Status Questionnaire of the
participants (n=21) during pre and post time points presented as percentages.
Single Items

Pre

Post

1- Work Working full-time
situation Working part-time
Unemployed looking for work
Unemployed because of my
health
Retired because of my health
Retired for some other reason

29%
9%
5%
38%

38%
5%
5%
33%

5%
14%

10%
9%

2- During the past month, how many days
did illness or injury keep you in bed all or
most of the time?

21%
out 31-day period

12%
out 31-day period

3- You cut down on the things you usually
do for one-half day or more because of
your illness or injury?

65%
out 31-day period

58%
out 31-day period

4- During the past
month, how satisfied
were you with your
sexual relationships?

Very satisfied
Satisfied
Not sure
Dissatisfied
Very dissatisfied
Did not have any
sexual
relationships.

5%
19%
10%
9%
14%
43%

10%
24%
14%
9%
10%
33%

5- How do you feel
about your health?

Very satisfied
Satisfied
Not sure
Dissatisfied
Very dissatisfied

0%
5%
9%
19%
67%

0%
14%
5%
43%
38%

6- During the past
month, about how
often did you get

Every day

10%

0%

Several times
/wk.

14%

24%
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together with friends
or relatives, such as
going out together,
visiting in each other's
home, or talking on the
telephone?

About once /wk.

14%

14%

2 or 3 times a
month
About 1 a month
Not at all

33%

14%

19%
10%

29%
19%

RAND-36 HrQoL. The post-test score of social functioning parameter (60
±24) was significantly higher than the pre-test score (44 ±27), t(20) = -3.525, p =
0.002, r = .76. In addition, there was a significant difference in the scores of pain
parameter. Pain scores in the post-test (53 ±25) was significantly higher than the
pre-test (42 ±30), t(20) = -2.134, p = 0.045, r = .46 (Table 5). There were no
significant differences between the pre and post-test scores in all of the other
parameters in this questionnaire.
Table 5. The outcome scores (points/100) of the RAND-36 questionnaire
(HrQoL) parameters of the participants (n = 21) during pre and post time points
presented as mean, SD, median and range. Paired t-test and Wilcoxon signed-rank
tests were used to explore significant differences between the two the time points.
Statistical significance was determined when p < 0.05. HrQoL: Health related
quality of life, Md: median, Rn: range.

Variables

Value

Pre

Post

p-value

Physical functioning

Mean, SD

43 ±29

47 ±27

0.280

Role limitations due to physical health

Md, Rn

0, 100

0, 100

0.461

Role limitations due to emotional problems

Md, Rn

21, 100

19, 100

0.726

Energy/fatigue

Md, Rn

20, 80

10, 80

0.906

Emotional well-being

Mean, SD

57 ±16

60 ±15

0.211

Social functioning

Mean, SD

44 ±27

60 ±24

0.002

Pain

Mean, SD

42 ±30

53 ±25

0.045

General health

Mean, SD

40 ±19

38 ±22

0.289
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Discussion
Our major novel findings are that in individuals with COVID-19 infection: 1)
self-reported dyspnea, work performance and social functioning scores
significantly improved in the post-testing time point compared to the pre-testing
time point; and 2) pain scores were significantly higher in the post-testing time
point compared the pre-testing time point. Based on our findings, we conclude
that many negative effects of COVID-19 on select physical, functional, and
psychosocial parameters among infected individuals persist for long period after
the date of infection with the virus and may in fact worsen over time.
Post-test score of self-reported dyspnea was significantly lower that the
pre-test score. This significant improvement might be explained by the non-severe
nature of COVID-19 infection among the participants in our study which may be
consistent with findings reported by others.9 Wu et al., indicated that severely
infected individuals with COVID-19 presented significantly higher number of
residual abnormal lung lesions (ground-glass and linear opacities) compared to
moderately infected individuals.9 In addition, the average time (recovery period)
from the date of infection to the post-test time point among the participants in our
study was (313 ± 76.1 days) which was longer than the recovery periods of (6
months ≈ 183 days) and (60-90 days) in the studies conducted by Wu et al.9 and
Raman et al.10 The length of time passed between the onset of the infection and
testing time point (recovery period) may explain the improvement in self-reported
dyspnea scores in our study versus persisting dyspnea symptoms in the latter two
studies.
Scores of walking, vigorous, moderate, and total physical activities
showed no improvements between the pre and post-test time despite having
abnormally lower scores during the pre-test time point as we have previously
reported.8 The lack of significant improvement in these scores may be occurred
due to behavioral reasons and external factors such as lockdowns.28,27 In addition,
this also may be at least partially explained by the persistent fatigue, and general
weakness2–4,21–23 as well as dyspnea that was initially present albeit improved by
the post-testing time point in the latter variable among the participants. It has been
also reported that individuals often suffer from functional and physical limitations
over a long period after being infected with viruses such as SARS-1.24,25
Furthermore, post-COVID-19 fatigue that results from central, psychological, and
peripheral factors could be another reason for this non-significant differences in
physical activity scores between the pre- and post-testing time points.26 Therefore,
the aforementioned factors may at least be partially contributed to the
nonsignificant improvements in physical activities reported among the
participants of this study.
In the FSQ, the post-test scores for work performance parameter were
significantly higher than pre-test scores. This possibly resulted from the
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improvements noticed in dyspnea scores among the participants at the post-testing
time point. It has been reported that dyspnea negatively affects perceived health
status as well as participation in physical activity.26 The rest of the parameters
(Basic ADL, intermediate ADL, mental health, social activities, and quality of
interactions) in this questionnaire did not show any significant differences
between the two-testing time point. The possible reasons behind the
nonsignificant differences may be due to post-COVID-19 fatigue,26 and home
confinement associated with public health measures27 the participants experienced
during the pandemic.28
For the parameter of social functioning in the RAND-36 HrQoL
questionnaire, the post testing-time point scores were significantly higher than the
pre-testing time point. This also can at least partially be explained by the
improvement noticed of dyspnea scores during the post-testing time point.29
Chronic dyspnea negatively affects the perception of the health status of the
person causing decreased physical activity, promoting muscular deconditioning,
anxiety, social isolation, and depression.30,31 Pain scores were higher during the
post-testing compared to the pre-testing time point. This increase may possibly be
resulted from lasting muscle pain (i.e., myalgia).32-33 In addition, repeated
lockdowns worldwide (varies from a region to another) led to increased periods of
sedentary activities which may cause inhibition of the motor neurons and lead to
fatigue6,26,34–36 and since fatigue and pain are reported to be associated, this might
increase the perception of pain among the infected individuals. Furthermore,
negative psychological consequences of being infected with COVID-19 include
post-traumatic stress symptoms, anxiety, confusion, depression, and anger may be
a significant contributor to fatigue then increase the perception of pain.26,37–39.
Although that pain increase noticed at the 3-month follow up can be at
least partially justified by the explanation provided earlier, participants were not
able to give further information about the nature and location of the pain at the
time of collecting the pre- and post-test data. It is noteworthy to mention that this
study was conducted in end of the first year and beginning of the second year of
the pandemic. Researchers of this study selected the questionnaires that were later
utilized based on the available information about COVID-19 at that time which in
turn were not designed to detect these specific features of the pain (i.e., nature and
location). As for the other parameters in this questionnaire, (physical functioning,
role limitations due to physical health, role limitations due emotional problems,
energy/fatigue, emotional well-being, and general health), there were no
significant differences between the pre- and post-testing time points. Possible
contributing factors to this outcome may include but not limited to repeated
policies of home confinement,28 social distancing, lockdowns,27 long lasting postCOVID-19 fatigue,26 reduced physical activity and quality of life8 as well as
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common consequences of COVID-19 such as anxiety, confusion, anger,
depression, and post-traumatic stress symptoms.26,37–39
In this study, we examined three-month recovery from common negative
effects of COVID-19 infection on select physical, functional, and psychosocial
parameters among infected individuals and their implications for rehabilitation
programs in this population. However, this study was not without limitations. The
date of the infection of COVID-19 survivors ranged from 1 to 11 month which
lends to a varied recovery time - this may be seen as a limitation as well as a
strength and demonstrative of prolonged consequences. In addition, we did not
have any method to validate the severity of illness during infection, thus, it may
be hard to generalize our findings to all COVID-19 survivors, although as with
most COVID-19 cases, most (17 out of 21) of the infected participants were never
hospitalized while only 4 were hospitalized as result of COVID-19 infection in
our cohort. Thus, most of the infected participants of this study can be considered
non-severe cases and representative. Similarly, as the majority of the COVID-19
infected participants in this study were not hospitalized, our sample of infected
participants does not represent individuals who are severely affected by COVID19 illness.
Conclusions
In our study, self-reported symptoms from objective measures indicate
that COVID-19 survivorship is linked with ongoing and persistent physical,
functional, and psychosocial deficits. Scores of dyspnea, work performance and
social functioning improved significantly during the post-testing time point.
However, pain scores were significantly higher and increased during the posttesting compared to the pre-testing time point. Our data have important
implications on the multidisciplinary rehabilitation programs in that it objectively
demonstrates long-lasting physical deficiencies as well as social and emotional
concerns for first time in non-severe COVID-19 infected individuals. Therefore,
designing mid- and long-term rehabilitation programs as well as providing up-todate information about the short- and long-term effects of COVID-19 infection
should be the proper approach to address these demonstrated deficits, and allay
uncertainty and anxiety concerns individuals might experience in the future.

Clinical Messages
1- Three months recovery time was enough to notice significant
improvements in dyspnea, work performance and social functioning
scores. However, pain scores increased among individuals infected with
COVID-19.
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2- Longer recovery time and rehabilitation programs may lead to more
improvements in physical, functional, and psychosocial variables among
COVID-19 infected individuals.
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